Advanced Search

Journal Navigation

Journal Home



Contact Us

Table of Contents

Click here to register today!

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, B. N.
Right arrow Articles by Hullett, D. A.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Graft, Vol. 5, No. 4, 199-204 (2002)
© 2002 SAGE Publications

An Antigen-Independent Important Hormone: Intrarenal Angiotensin II (AII) as a Key to Understanding Chronic Allograft Nephropathy

Bryan N. Becker

Lynn M. Jacobson

Debra A. Hullett

Chronic allograft nephropathy (CAN) is a multifactorial lesion. There has been a graduallyincreasing recognition of the importance of antigen-independent factors influencingthe development and progression of CAN. One important antigen-independent hormonein this setting is angiotensin II (AII), which is associated with progressive kidneydisease. Although the pathogenesis of native kidney disease may differ from CAN, thechronic progressive nature of both entities raises the hypothesis that AII also has a rolein CAN. However, AII also serves as a theoretical focal point, linking many of the factorsinvolved in CAN. Fortunately, we have therapies, angiotensin converting enzyme inhibitors(ACE-I), and type 1 angiotensin II receptor (AT1 R) antagonists that can alter theeffects of AII in grafts. We can treat renal transplant recipients with such therapies in thehopes of preserving graft function. At the same time, given AII's apparent central role inCAN, we can potentially glean novel information as to the pathogenesis and optimaltreatment of CAN.

Key Words: angiotensin II • chronic allograft nephropathy • kidney transplantation

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?